Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclide Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Technetium-99
1.2.3 Iodine-123
1.2.4 Iodine-125
1.2.5 Iodine-131
1.2.6 Fluorine-18
1.2.7 Gallium-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclide Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Therapeutic Use
1.3.3 Diagnostic Use
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclide Drugs Market Perspective (2018-2029)
2.2 Nuclide Drugs Growth Trends by Region
2.2.1 Global Nuclide Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nuclide Drugs Historic Market Size by Region (2018-2024)
2.2.3 Nuclide Drugs Forecasted Market Size by Region (2024-2029)
2.3 Nuclide Drugs Market Dynamics
2.3.1 Nuclide Drugs Industry Trends
2.3.2 Nuclide Drugs Market Drivers
2.3.3 Nuclide Drugs Market Challenges
2.3.4 Nuclide Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclide Drugs Players by Revenue
3.1.1 Global Top Nuclide Drugs Players by Revenue (2018-2024)
3.1.2 Global Nuclide Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Nuclide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclide Drugs Revenue
3.4 Global Nuclide Drugs Market Concentration Ratio
3.4.1 Global Nuclide Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclide Drugs Revenue in 2022
3.5 Nuclide Drugs Key Players Head office and Area Served
3.6 Key Players Nuclide Drugs Product Solution and Service
3.7 Date of Enter into Nuclide Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclide Drugs Breakdown Data by Type
4.1 Global Nuclide Drugs Historic Market Size by Type (2018-2024)
4.2 Global Nuclide Drugs Forecasted Market Size by Type (2024-2029)
5 Nuclide Drugs Breakdown Data by Application
5.1 Global Nuclide Drugs Historic Market Size by Application (2018-2024)
5.2 Global Nuclide Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nuclide Drugs Market Size (2018-2029)
6.2 North America Nuclide Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nuclide Drugs Market Size by Country (2018-2024)
6.4 North America Nuclide Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclide Drugs Market Size (2018-2029)
7.2 Europe Nuclide Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nuclide Drugs Market Size by Country (2018-2024)
7.4 Europe Nuclide Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclide Drugs Market Size (2018-2029)
8.2 Asia-Pacific Nuclide Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nuclide Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Nuclide Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclide Drugs Market Size (2018-2029)
9.2 Latin America Nuclide Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nuclide Drugs Market Size by Country (2018-2024)
9.4 Latin America Nuclide Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclide Drugs Market Size (2018-2029)
10.2 Middle East & Africa Nuclide Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nuclide Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Nuclide Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclide Drugs Introduction
11.1.4 GE Healthcare Revenue in Nuclide Drugs Business (2018-2024)
11.1.5 GE Healthcare Recent Development
11.2 Cardinal Health
11.2.1 Cardinal Health Company Detail
11.2.2 Cardinal Health Business Overview
11.2.3 Cardinal Health Nuclide Drugs Introduction
11.2.4 Cardinal Health Revenue in Nuclide Drugs Business (2018-2024)
11.2.5 Cardinal Health Recent Development
11.3 Curium Pharma
11.3.1 Curium Pharma Company Detail
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Nuclide Drugs Introduction
11.3.4 Curium Pharma Revenue in Nuclide Drugs Business (2018-2024)
11.3.5 Curium Pharma Recent Development
11.4 Lantheus Medical Imaging, Inc.
11.4.1 Lantheus Medical Imaging, Inc. Company Detail
11.4.2 Lantheus Medical Imaging, Inc. Business Overview
11.4.3 Lantheus Medical Imaging, Inc. Nuclide Drugs Introduction
11.4.4 Lantheus Medical Imaging, Inc. Revenue in Nuclide Drugs Business (2018-2024)
11.4.5 Lantheus Medical Imaging, Inc. Recent Development
11.5 Eczacıbaşı Monrol Nuclear Products
11.5.1 Eczacıbaşı Monrol Nuclear Products Company Detail
11.5.2 Eczacıbaşı Monrol Nuclear Products Business Overview
11.5.3 Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Introduction
11.5.4 Eczacıbaşı Monrol Nuclear Products Revenue in Nuclide Drugs Business (2018-2024)
11.5.5 Eczacıbaşı Monrol Nuclear Products Recent Development
11.6 Novartis International AG
11.6.1 Novartis International AG Company Detail
11.6.2 Novartis International AG Business Overview
11.6.3 Novartis International AG Nuclide Drugs Introduction
11.6.4 Novartis International AG Revenue in Nuclide Drugs Business (2018-2024)
11.6.5 Novartis International AG Recent Development
11.7 Siemens
11.7.1 Siemens Company Detail
11.7.2 Siemens Business Overview
11.7.3 Siemens Nuclide Drugs Introduction
11.7.4 Siemens Revenue in Nuclide Drugs Business (2018-2024)
11.7.5 Siemens Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Detail
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Nuclide Drugs Introduction
11.8.4 China Isotope & Radiation Revenue in Nuclide Drugs Business (2018-2024)
11.8.5 China Isotope & Radiation Recent Development
11.9 Yantai Dongcheng Pharmaceutical
11.9.1 Yantai Dongcheng Pharmaceutical Company Detail
11.9.2 Yantai Dongcheng Pharmaceutical Business Overview
11.9.3 Yantai Dongcheng Pharmaceutical Nuclide Drugs Introduction
11.9.4 Yantai Dongcheng Pharmaceutical Revenue in Nuclide Drugs Business (2018-2024)
11.9.5 Yantai Dongcheng Pharmaceutical Recent Development
11.10 Jubilant Life Sciences
11.10.1 Jubilant Life Sciences Company Detail
11.10.2 Jubilant Life Sciences Business Overview
11.10.3 Jubilant Life Sciences Nuclide Drugs Introduction
11.10.4 Jubilant Life Sciences Revenue in Nuclide Drugs Business (2018-2024)
11.10.5 Jubilant Life Sciences Recent Development
11.11 Bracco
11.11.1 Bracco Company Detail
11.11.2 Bracco Business Overview
11.11.3 Bracco Nuclide Drugs Introduction
11.11.4 Bracco Revenue in Nuclide Drugs Business (2018-2024)
11.11.5 Bracco Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nuclide Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Technetium-99
Table 3. Key Players of Iodine-123
Table 4. Key Players of Iodine-125
Table 5. Key Players of Iodine-131
Table 6. Key Players of Fluorine-18
Table 7. Key Players of Gallium-67
Table 8. Key Players of Others
Table 9. Global Nuclide Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Nuclide Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Nuclide Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 12. Global Nuclide Drugs Market Share by Region (2018-2024)
Table 13. Global Nuclide Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Nuclide Drugs Market Share by Region (2024-2029)
Table 15. Nuclide Drugs Market Trends
Table 16. Nuclide Drugs Market Drivers
Table 17. Nuclide Drugs Market Challenges
Table 18. Nuclide Drugs Market Restraints
Table 19. Global Nuclide Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 20. Global Nuclide Drugs Market Share by Players (2018-2024)
Table 21. Global Top Nuclide Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclide Drugs as of 2022)
Table 22. Ranking of Global Top Nuclide Drugs Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Nuclide Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Nuclide Drugs Product Solution and Service
Table 26. Date of Enter into Nuclide Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 29. Global Nuclide Drugs Revenue Market Share by Type (2018-2024)
Table 30. Global Nuclide Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Nuclide Drugs Revenue Market Share by Type (2024-2029)
Table 32. Global Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 33. Global Nuclide Drugs Revenue Market Share by Application (2018-2024)
Table 34. Global Nuclide Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Nuclide Drugs Revenue Market Share by Application (2024-2029)
Table 36. North America Nuclide Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Nuclide Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 41. Europe Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Nuclide Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Nuclide Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 44. Asia-Pacific Nuclide Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Nuclide Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 47. Latin America Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Nuclide Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 50. Middle East & Africa Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclide Drugs Product
Table 54. GE Healthcare Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Cardinal Health Company Detail
Table 57. Cardinal Health Business Overview
Table 58. Cardinal Health Nuclide Drugs Product
Table 59. Cardinal Health Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 60. Cardinal Health Recent Development
Table 61. Curium Pharma Company Detail
Table 62. Curium Pharma Business Overview
Table 63. Curium Pharma Nuclide Drugs Product
Table 64. Curium Pharma Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 65. Curium Pharma Recent Development
Table 66. Lantheus Medical Imaging, Inc. Company Detail
Table 67. Lantheus Medical Imaging, Inc. Business Overview
Table 68. Lantheus Medical Imaging, Inc. Nuclide Drugs Product
Table 69. Lantheus Medical Imaging, Inc. Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 70. Lantheus Medical Imaging, Inc. Recent Development
Table 71. Eczacıbaşı Monrol Nuclear Products Company Detail
Table 72. Eczacıbaşı Monrol Nuclear Products Business Overview
Table 73. Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Product
Table 74. Eczacıbaşı Monrol Nuclear Products Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 75. Eczacıbaşı Monrol Nuclear Products Recent Development
Table 76. Novartis International AG Company Detail
Table 77. Novartis International AG Business Overview
Table 78. Novartis International AG Nuclide Drugs Product
Table 79. Novartis International AG Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 80. Novartis International AG Recent Development
Table 81. Siemens Company Detail
Table 82. Siemens Business Overview
Table 83. Siemens Nuclide Drugs Product
Table 84. Siemens Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 85. Siemens Recent Development
Table 86. China Isotope & Radiation Company Detail
Table 87. China Isotope & Radiation Business Overview
Table 88. China Isotope & Radiation Nuclide Drugs Product
Table 89. China Isotope & Radiation Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 90. China Isotope & Radiation Recent Development
Table 91. Yantai Dongcheng Pharmaceutical Company Detail
Table 92. Yantai Dongcheng Pharmaceutical Business Overview
Table 93. Yantai Dongcheng Pharmaceutical Nuclide Drugs Product
Table 94. Yantai Dongcheng Pharmaceutical Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 95. Yantai Dongcheng Pharmaceutical Recent Development
Table 96. Jubilant Life Sciences Company Detail
Table 97. Jubilant Life Sciences Business Overview
Table 98. Jubilant Life Sciences Nuclide Drugs Product
Table 99. Jubilant Life Sciences Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 100. Jubilant Life Sciences Recent Development
Table 101. Bracco Company Detail
Table 102. Bracco Business Overview
Table 103. Bracco Nuclide Drugs Product
Table 104. Bracco Revenue in Nuclide Drugs Business (2018-2024) & (US$ Million)
Table 105. Bracco Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclide Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Nuclide Drugs Market Share by Type: 2022 VS 2029
Figure 3. Technetium-99 Features
Figure 4. Iodine-123 Features
Figure 5. Iodine-125 Features
Figure 6. Iodine-131 Features
Figure 7. Fluorine-18 Features
Figure 8. Gallium-67 Features
Figure 9. Others Features
Figure 10. Global Nuclide Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Nuclide Drugs Market Share by Application: 2022 VS 2029
Figure 12. Therapeutic Use Case Studies
Figure 13. Diagnostic Use Case Studies
Figure 14. Nuclide Drugs Report Years Considered
Figure 15. Global Nuclide Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Nuclide Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Nuclide Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Nuclide Drugs Market Share by Players in 2022
Figure 19. Global Top Nuclide Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclide Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Nuclide Drugs Revenue in 2022
Figure 21. North America Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Nuclide Drugs Market Share by Country (2018-2029)
Figure 23. United States Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Nuclide Drugs Market Share by Country (2018-2029)
Figure 27. Germany Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Nuclide Drugs Market Share by Region (2018-2029)
Figure 35. China Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Nuclide Drugs Market Share by Country (2018-2029)
Figure 43. Mexico Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Nuclide Drugs Market Share by Country (2018-2029)
Figure 47. Turkey Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Nuclide Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. GE Healthcare Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 50. Cardinal Health Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 51. Curium Pharma Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 52. Lantheus Medical Imaging, Inc. Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 53. Eczacıbaşı Monrol Nuclear Products Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 54. Novartis International AG Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 55. Siemens Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 56. China Isotope & Radiation Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 57. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 58. Jubilant Life Sciences Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 59. Bracco Revenue Growth Rate in Nuclide Drugs Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed